Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: Results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts

Airley, RE, Phillips, RM, Evans, AR, Double, J, Burger, AM, Feibig, HH, West, CML and Stratford, IJ (2005) Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: Results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. INTERNATIONAL JOURNAL OF ONCOLOGY, 26 (6). pp. 1477-1484. ISSN 1019-6439

[img]
Preview
Text
airley 2005.pdf - Published Version

Download (2MB) | Preview

Abstract

Tumour hypoxia confers poor prognosis in a wide range of solid tumours, due to an increased malignancy, increased likelihood of metastasis and treatment resistance. Poorly oxygenated tumours are resistant to both radiation therapy and chemotherapy. However, although the link between radiation therapy and hypoxia is well established
in a range of clinical studies, evidence of its influence on chemotherapy response is lacking. In this study, a panel of human tumour-derived xenografts that have been characterised previously for in vivo response to a large series of anti-cancer agents, and have been found to show chemosensitivities that correlate strongly with the parent tumour, were used to address this issue. Immunohistochemistry was carried out on formalinfixed, paraffin-embedded sections of xenograft samples to detect expression of the intrinsic hypoxia marker Glut-1 and adducts of the bioreductive hypoxia marker pimonidazole. Glut-1 scores correlated significantly with T/C values for CCNU sensitivity (r=0.439, P=0.036, n=23) and showed a borderline significant correlation with dacarbazine T/C (r=0.405, P=0.076, n=20). However, there was no correlation between both Glut-1 and pimonidazole scores and T/C obtained for the bioreductive drug mitomycin C. The use of human tumour-derived xenografts offers a potentially useful way of using archival material to determine the influence of hypoxia and other tumour-microenvironmental factors on chemosensitivity without the direct use of human subjects.

Item Type: Article
Uncontrolled Keywords: 1112 Oncology And Carcinogenesis
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Pharmacy & Biomolecular Sciences
Publisher: PROFESSOR D A SPANDIDOS
Related URLs:
Date Deposited: 13 Nov 2015 10:40
Last Modified: 04 Sep 2021 13:48
URI: https://researchonline.ljmu.ac.uk/id/eprint/2336
View Item View Item